Relationship between sST2 levels and prognosis in patients with pulmonary arterial hypertension


Sahin A., KAYA H., GÜL İ.

ANNALS OF CLINICAL AND ANALYTICAL MEDICINE, vol.11, pp.172-177, 2020 (Peer-Reviewed Journal) identifier

  • Publication Type: Article / Article
  • Volume: 11
  • Publication Date: 2020
  • Doi Number: 10.4328/acam.20204
  • Journal Name: ANNALS OF CLINICAL AND ANALYTICAL MEDICINE
  • Journal Indexes: Emerging Sources Citation Index
  • Page Numbers: pp.172-177

Abstract

Aim: Soluble Suppression of Tumorigenicity-2 (sST2) was approved for non-invasive risk assessment and its prognostic benefits were monitored in some heterogeneous pulmonary hypertension cohorts. In this study, we aimed to evaluate the relationship of sST2 use with clinical deterioration and survival in pulmonary arterial hypertension (PAH) patients.